ProTECT
ProTECT, licence 80145956: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Canpower health inc.
- NPN or DIN-HM
- 80145956
- Status
- Active licence
- Licence date
- 8 December 2025
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lycopène tout trans Source : Solanum lycopersicum - Chair (fruit) | 4.0 mg | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 95.0 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 150.0 mg | Not calculated |
| Zinc | 12.5 mg | Not calculated |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 10.0 mg | Not calculated |
| Bore Source : Citrate de bore | 350.0 Microgrammes | Not calculated |
| Manganèse Source : Produit de chélation de manganèse (II) et de protéine végétale hydrolysée (PVH) | 4.5 mg | Not calculated |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 100.0 Microgrammes | Not calculated |
| Cucurbita pepo Source : Cucurbita pepo - Graine | 200.0 mg | Not calculated |
| Urtica dioica Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50.0 mg | Not calculated |
| Serenoa repens Potency : 90.0 % Free fatty acids, esters, and sterols | 160.0 mg | Not calculated |
| Prunus africana Source : Prunus africana - Stem bark Potency : 25.0 % Phytosterols | 50.0 mg | Not calculated |
Non-medicinal ingredients
Vitamine E, Huile de tournesol, Cire d'abeille jaune, Poudre de caroube, Lécithine, Gélatine, Eau purifiée, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Hommes | minimum: 19.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Used in Herbal Medicine to help relieve the urologic symptoms associated with mild to moderate benign prostatic hyperplasia (BPH) (e.g., weak urine flow/incomplete voiding/frequent daytime/ nighttime urination). A factor in normal growth and development. A factor in the maintenance of good health. Contributes to maintaining general health. Helps in connective tissue formation. Helps in energy metabolism/(and) tissue formation. Helps in the development and maintenance of bones. Helps normal growth and development. Helps to form red blood cells. Helps to maintain/support healthy bones/hair/nail/(and) skin. Helps to maintain/support healthy skin. Helps to maintain/support immune function/the immune system. Helps to maintain/support the body's ability to metabolize nutrients. Helps to support prostate health. Maintains/supports healthy bones/hair/nail/(and) skin. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/Provides an antioxidant that helps protect against oxidative stress.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80145956
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.